...
首页> 外文期刊>Annals of surgical oncology >Resection of pulmonary metastases from colon and rectal cancer: Factors to predict survival differ regarding to the origin of the primary tumor
【24h】

Resection of pulmonary metastases from colon and rectal cancer: Factors to predict survival differ regarding to the origin of the primary tumor

机译:结肠癌和直肠癌肺转移的切除:预测生存的因素因原发肿瘤的来源而异

获取原文
获取原文并翻译 | 示例

摘要

Background. The purpose of the present study was to determine differences in prognostic factors for survival of patients with pulmonary metastases resected in curative intent from colon or rectum cancer. Methods. Between 1980 and 2006, prognostic factors after resection of pulmonary metastases in 171 patients with primary rectum or colon tumor were evaluated. Survival of patients after surgical metastasectomy was compared with that of patients receiving standard chemotherapy by matched-pair analysis. Results. Median survival after pulmonary resection was 35.2 months (confidence interval 27.3-43.2). One-, 3-, and 5-year survival for patients following R0 resection was 88.8, 52.1, and 32.9 % respectively. Complete metastasectomy (R0), UICC stage of the primary tumor, pleural infiltration, and hilar or mediastinal lymph node metastases are independent prognostic factors for survival. Matched-pair analysis confirmed that pulmonary metastasectomy significantly improved survival. Although no difference in survival for patients with pulmonary metastases from lower rectal compared to upper rectal or colon cancer was observed, factors to predict survival are different for patients with lower and middle rectal cancer (R0, mediastinal and/or hilar lymph nodes, gender, UICC stage) compared with patients with upper rectal or colon cancer (R0, number of metastases). Conclusions. Our results indicate that distinct prognostic factors exist for patients with pulmonary metastases from lower rectal compared with upper rectal or colon cancer. This supports the notion that colorectal cancer should not be considered as a single-tumor entity. Metastasectomy, especially after complete resection resulted in a dramatic improvement of survival compared with patients treated with chemotherapy alone.
机译:背景。本研究的目的是确定因结肠癌或直肠癌的治疗目的而切除的肺转移患者生存的预后因素差异。方法。在1980年至2006年之间,对171例原发直肠或结肠肿瘤患者的肺转移瘤切除后的预后因素进行了评估。通过配对分析将手术转移的患者的生存与接受标准化疗的患者的生存进行了比较。结果。肺切除术后中位生存期为35.2个月(置信区间27.3-43.2)。 R0切除后患者的一年,三年和5年生存率分别为88.8%,52.1和32.9%。完全转移术(R0),原发性肿瘤的UICC分期,胸膜浸润以及肺门或纵隔淋巴结转移是生存的独立预后因素。配对分析证实,肺转移切除术可显着提高生存率。尽管与上直肠癌或结肠癌相比,下直肠癌肺转移患者的生存率没有差异,但预测中下直肠癌患者生存率的因素有所不同(R0,纵隔和/或肺门淋巴结转移,性别, UICC分期)与上直肠癌或结肠癌(R0,转移数)的患者进行比较。结论我们的结果表明,与上直肠癌或结肠癌相比,来自下直肠的肺转移患者存在不同的预后因素。这支持了不应将大肠癌视为单肿瘤实体的观点。与仅接受化疗的患者相比,尤其是完全切除后的转移瘤切除术可显着提高生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号